Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas (FIX-IT1)
Primary Purpose
Anorectal Abscess, Fistula in Ano
Status
Terminated
Phase
Phase 3
Locations
Study Type
Interventional
Intervention
Collagen paste
Sponsored by
About this trial
This is an interventional treatment trial for Anorectal Abscess
Eligibility Criteria
Inclusion Criteria:
o Clinical diagnosis of Cryptoglandular fistula in ano.
Exclusion Criteria:
- Insulin dependent diabetes
- Thyroid disease
- Fistula secondary to Crohn's disease/Ulcerative Colitis
- Clinical or radiological evidence of secondary tracts.
- Complex fistula tracts on MRI scan such as Horseshoe fistula, anorectal-vaginal fistula
- Patients refusing informed consent for admission to the study.
- Previous fistulotomy/fistulectomy
- Pregnancy
- Patients unable to consent
- Patients not suitable for MRI scan those with- Cochlear implant, Permanent pacemaker, Implanted metal work, Aneurysm clips, Claustrophobia, Metallic foreign body
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Collagen paste
Arm Description
Injection of Permacol Collagen paste into the fistula tract.
Outcomes
Primary Outcome Measures
Fistula Healing rate at 3 months
Healing of fistula as evidenced by MRI of the ano-rectum.
Fistula Healing Rate at 12 months
This will be assessed by a telephonic questionnaire at 12 months following intervention
Secondary Outcome Measures
Complication rate
Any complications resulting from participation in the the trial will be assessed on clinical and telephonic follow up. Clavien and Dindo Classification will be used to assess the severity of complications.
Faecal Incontinence questionnaire (Wexner)
To assess any adverse impact of intervention on continence
Faecal Incontinence quality of life questionnaire (FIQL)
To assess the impact on the quality of life of the participants
Pain Score
Visual analogue score
Full Information
NCT ID
NCT02686580
First Posted
December 1, 2015
Last Updated
September 10, 2019
Sponsor
Royal Devon and Exeter NHS Foundation Trust
1. Study Identification
Unique Protocol Identification Number
NCT02686580
Brief Title
Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas
Acronym
FIX-IT1
Official Title
Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Terminated
Why Stopped
Unable to recruit participants for this study
Study Start Date
February 1, 2016 (Actual)
Primary Completion Date
October 1, 2018 (Actual)
Study Completion Date
December 1, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Royal Devon and Exeter NHS Foundation Trust
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study is designed to assess the effectiveness of porcine cross-linked collagen paste for the treatment of patients with ano-rectal abscess with underlying cryptoglandular fistula in ano.
Detailed Description
Most anal fistulae are thought to arise as a result of the infection of anal glands. This infection frequently presents as an anorectal abscess which requires drainage of the abscess under a general anaesthetic. Abscess and fistula should be considered as the acute and chronic phase of the same anorectal infection.The abscess represents the acute inflammatory event, whereas the fistula is representative of the chronic process. At the time of drainage of the anorectal abscess, the underlying fistulas frequently go undetected. As a result, patients present with a fistula in ano several months later.
In this study, the investigators aim to identify the underlying fistula in patients with a perianal abscess with the help of an MRI Scan done in the acute setting. Participants with a confirmed fistula on the MRI scan have their abscess treated as per convention. However, a repeat examination under anaesthetic is performed 7-'10 days later when the fistula tract is identified and treated with injection of the porcine collagen paste into the fistula tract. Participants are followed up clinically and radiologically to assess the effectiveness of the intervention.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anorectal Abscess, Fistula in Ano
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
2 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Collagen paste
Arm Type
Experimental
Arm Description
Injection of Permacol Collagen paste into the fistula tract.
Intervention Type
Biological
Intervention Name(s)
Collagen paste
Intervention Description
Permacol cross-linked collagen paste, 2.5-3.5 mls to be injected into the MRI defined fistula tracts 7-10 days following drainage of the anorectal abscess.
Primary Outcome Measure Information:
Title
Fistula Healing rate at 3 months
Description
Healing of fistula as evidenced by MRI of the ano-rectum.
Time Frame
3 months
Title
Fistula Healing Rate at 12 months
Description
This will be assessed by a telephonic questionnaire at 12 months following intervention
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Complication rate
Description
Any complications resulting from participation in the the trial will be assessed on clinical and telephonic follow up. Clavien and Dindo Classification will be used to assess the severity of complications.
Time Frame
12 months
Title
Faecal Incontinence questionnaire (Wexner)
Description
To assess any adverse impact of intervention on continence
Time Frame
At recruitment, 7-10 days, 6 weeks and 6 months
Title
Faecal Incontinence quality of life questionnaire (FIQL)
Description
To assess the impact on the quality of life of the participants
Time Frame
At recruitment, 7-10 days, 6 weeks and 6 months
Title
Pain Score
Description
Visual analogue score
Time Frame
At recruitment, 7-10 days, 6 weeks and 6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
o Clinical diagnosis of Cryptoglandular fistula in ano.
Exclusion Criteria:
Insulin dependent diabetes
Thyroid disease
Fistula secondary to Crohn's disease/Ulcerative Colitis
Clinical or radiological evidence of secondary tracts.
Complex fistula tracts on MRI scan such as Horseshoe fistula, anorectal-vaginal fistula
Patients refusing informed consent for admission to the study.
Previous fistulotomy/fistulectomy
Pregnancy
Patients unable to consent
Patients not suitable for MRI scan those with- Cochlear implant, Permanent pacemaker, Implanted metal work, Aneurysm clips, Claustrophobia, Metallic foreign body
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Neil J Smart, MBBS PhD FRCS
Organizational Affiliation
Royal Devon and Exeter NHS Foundation Trust
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas
We'll reach out to this number within 24 hrs